These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 28550831)

  • 1. [Relevance of Omega-3 and Omega-6 / Omega-3 Ratio in Preventing Cognitive Impairment].
    Nunes B; Pinho C; Sousa C; Melo AR; Bandarra N; Silva MC
    Acta Med Port; 2017 Mar; 30(3):213-223. PubMed ID: 28550831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment.
    Oulhaj A; Jernerén F; Refsum H; Smith AD; de Jager CA
    J Alzheimers Dis; 2016; 50(2):547-57. PubMed ID: 26757190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lower ratio of omega-6 to omega-3 fatty acids predicts better hippocampus-dependent spatial memory and cognitive status in older adults.
    Andruchow ND; Konishi K; Shatenstein B; Bohbot VD
    Neuropsychology; 2017 Oct; 31(7):724-734. PubMed ID: 28394147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analytic review of polyunsaturated fatty acid compositions in dementia.
    Lin PY; Chiu CC; Huang SY; Su KP
    J Clin Psychiatry; 2012 Sep; 73(9):1245-54. PubMed ID: 22938939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Omega-6/omega-3 ratio and cognition in children with epilepsy].
    Bahagat KA; Elhady M; Aziz AA; Youness ER; Zakzok E
    An Pediatr (Engl Ed); 2019 Aug; 91(2):88-95. PubMed ID: 30660389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association between Cerebral White Matter Lesions and Plasma Omega-3 to Omega-6 Polyunsaturated Fatty Acids Ratio to Cognitive Impairment Development.
    Suwa M; Yamaguchi S; Komori T; Kajimoto S; Kino M
    Biomed Res Int; 2015; 2015():153437. PubMed ID: 26583090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary and Serum Omega-6/Omega-3 Fatty Acids Are Associated with Physical and Metabolic Function in Stroke Survivors.
    Serra MC; Ryan AS; Hafer-Macko CE; Yepes M; Nahab FB; Ziegler TR
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32155696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower omega-3 fatty acid intake and status are associated with poorer cognitive function in older age: A comparison of individuals with and without cognitive impairment and Alzheimer's disease.
    Phillips MA; Childs CE; Calder PC; Rogers PJ
    Nutr Neurosci; 2012 Nov; 15(6):271-7. PubMed ID: 22824373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial.
    Cukierman-Yaffe T; Bosch J; Diaz R; Dyal L; Hancu N; Hildebrandt P; Lanas F; Lewis BS; Marre M; Yale JF; Yusuf S; Gerstein HC;
    Lancet Diabetes Endocrinol; 2014 Jul; 2(7):562-72. PubMed ID: 24898834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ratio of dietary ω-3 and ω-6 fatty acids-independent determinants of muscle mass-in hemodialysis patients with diabetes.
    Wong TC; Chen YT; Wu PY; Chen TW; Chen HH; Chen TH; Hsu YH; Yang SH
    Nutrition; 2016 Sep; 32(9):989-94. PubMed ID: 27157471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
    Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental retardation is associated with plasma omega-3 fatty acid levels and the omega-3/omega-6 ratio in children.
    Neggers YH; Kim EK; Song JM; Chung EJ; Um YS; Park T
    Asia Pac J Clin Nutr; 2009; 18(1):22-8. PubMed ID: 19329391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 Fatty Acids: Repurposing Opportunities for Cognition and Biobehavioral Disturbances in MCI and Dementia.
    Knöchel C; Voss M; Gruter F; Alves GS; Matura S; Sepanski B; Stablein M; Kraft D; Prvulovic D; Carvalho AF; Reif A; Oertel-Knochel V
    Curr Alzheimer Res; 2017; 14(3):240-254. PubMed ID: 27335040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased ω-3 polyunsaturated fatty acid/arachidonic acid ratios and upregulation of signaling mediator in individuals with autism spectrum disorders.
    Yui K; Imataka G; Kawasak Y; Yamada H
    Life Sci; 2016 Jan; 145():205-12. PubMed ID: 26724495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-6 and omega-3 polyunsaturated fatty acid levels are reduced in whole blood of Italian patients with a recent myocardial infarction: the AGE-IM study.
    Marangoni F; Novo G; Perna G; Perrone Filardi P; Pirelli S; Ceroti M; Querci A; Poli A
    Atherosclerosis; 2014 Feb; 232(2):334-8. PubMed ID: 24468146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of erythrocyte eicosapentaenoic acid and physical activity predicts reduced risk of mild cognitive impairment.
    Street SJ; Parletta N; Milte C; Sullivan K; Hills AP; Buckley J; Howe P
    Aging Ment Health; 2015; 19(10):885-91. PubMed ID: 25374153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study.
    Heude B; Ducimetière P; Berr C;
    Am J Clin Nutr; 2003 Apr; 77(4):803-8. PubMed ID: 12663275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of long chain polyunsaturated fatty acids and ornithine concentrations on complications after renal transplant.
    Alexander JW; Goodman HR; Succop P; Light JA; Kuo PC; Moser AB; James JH; Woodle ES
    Exp Clin Transplant; 2008 Jun; 6(2):118-26. PubMed ID: 18816238
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.